Drug Database
Back to search

France· FR:66848831

SYMKEVI 100 mg/150 mg, comprimé pelliculé

A ivacaftor and tezacaftor product containing tezacaftor + ivacaftor, registered in France by VERTEX PHARMACEUTICALS (EUROPE) ROYAUME-UNI), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R07AX31

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSYMKEVI 100 mg/150 mg, comprimé pelli…ATCR07AX31REGISTER NO.FR:66848831PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tezacaftor + ivacaftorAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ivacaftor and tezacaftor is registered in 15 of 19 countries.

Countries holding a registration under ATC R07AX31 (ivacaftor and tezacaftor), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search ivacaftor and tezacaftor products by name

Ivacaftor and tezacaftor · ATC R07AX31

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TEZACAFTOR + IVACAFTOR
Manufacturer
VERTEX PHARMACEUTICALS (EUROPE) ROYAUME-UNI)
Country
France (FR)
ATC code
R07AX31
ATC class
Ivacaftor and tezacaftor
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930157848
    plaquette(s) polychlortrifluoroéthylène PVC aluminium de 28 comprimé(s)
    EUR 4.06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ivacaftor and tezacaftor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivacaftor and tezacaftor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Symkevi
  • Liechtenstein · Symkevi
  • Norway · Symkevi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7393b73-a3f8-4a26-b307-d6bf864edd52
GET /v1/drugs/c7393b73-a3f8-4a26-b307-d6bf864edd52?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66848831",
  "date_amm": "2018-10-31",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/18/1306",
  "substance": "TEZACAFTOR + IVACAFTOR",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about ivacaftor and tezacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console